Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
87.21 USD | +0.58% | +0.46% | -17.37% |
04-25 | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
04-25 | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
Sales 2024 * | 2.8B 2.99B 239B | Sales 2025 * | 2.73B 2.92B 234B | Capitalization | 19.69B 21.05B 1,686B |
---|---|---|---|---|---|
Net income 2024 * | -552M -590M -47.26B | Net income 2025 * | -504M -539M -43.15B | EV / Sales 2024 * | 2.04 x |
Net cash position 2024 * | 13.98B 14.94B 1,197B | Net cash position 2025 * | 13.65B 14.59B 1,168B | EV / Sales 2025 * | 2.21 x |
P/E ratio 2024 * |
-35.7
x | P/E ratio 2025 * |
-43.8
x | Employees | 6,133 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.48% |
Latest transcript on BioNTech SE
1 day | +0.58% | ||
1 week | +0.46% | ||
Current month | -5.46% | ||
1 month | -4.90% | ||
3 months | -8.01% | ||
6 months | -9.76% | ||
Current year | -17.37% |
Managers | Title | Age | Since |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 01/06/08 |
Özlem Türeci
FOU | Founder | 57 | 01/06/08 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 30/06/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 31/12/21 |
Director/Board Member | 67 | 01/06/08 | |
Helmut Jeggle
CHM | Chairman | 53 | 01/06/08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.92% | 1 M€ | -5.79% | - | |
2.63% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 87.21 | +0.58% | 355,731 |
25/04/24 | 86.71 | -1.57% | 438,099 |
24/04/24 | 88.09 | -0.45% | 281,679 |
23/04/24 | 88.49 | +0.55% | 362,446 |
22/04/24 | 88.01 | +1.38% | 528,474 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.37% | 21.02B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B | |
-24.71% | 8.24B |
- Stock Market
- Equities
- BNTX Stock